Monomorphic Ventricular Arrhythmias in Athletes.

Jeffrey J Hsu, Ali Nsair, Jamil A Aboulhosn, Tamara B Horwich, Ravi H Dave, Kevin M Shannon, Noel G Boyle, Kalyanam Shivkumar, Jason S Bradfield
Author Information
  1. Jeffrey J Hsu: UCLA Sports Cardiology Center Los Angeles CA, US.
  2. Ali Nsair: UCLA Sports Cardiology Center Los Angeles CA, US.
  3. Jamil A Aboulhosn: UCLA Sports Cardiology Center Los Angeles CA, US.
  4. Tamara B Horwich: UCLA Sports Cardiology Center Los Angeles CA, US.
  5. Ravi H Dave: UCLA Sports Cardiology Center Los Angeles CA, US.
  6. Kevin M Shannon: UCLA Sports Cardiology Center Los Angeles CA, US.
  7. Noel G Boyle: UCLA Cardiac Arrhythmia Center Los Angeles CA, US.
  8. Kalyanam Shivkumar: UCLA Cardiac Arrhythmia Center Los Angeles CA, US.
  9. Jason S Bradfield: UCLA Sports Cardiology Center Los Angeles CA, US.

Abstract

Ventricular arrhythmias are challenging to manage in athletes with concern for an elevated risk of sudden cardiac death (SCD) during sports competition. Monomorphic ventricular arrhythmias (MMVA), while often benign in athletes with a structurally normal heart, are also associated with a unique subset of idiopathic and malignant substrates that must be clearly defined. A comprehensive evaluation for structural and/or electrical heart disease is required in order to exclude cardiac conditions that increase risk of SCD with exercise, such as hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. Unique issues for physicians who manage this population include navigating athletes through the decision of whether they can safely continue their chosen sport. In the absence of structural heart disease, therapies such as radiofrequency catheter ablation are very effective for certain arrhythmias and may allow for return to competitive sports participation. In this comprehensive review, we summarise the recommendations for evaluating and managing athletes with MMVA.

Keywords

References

  1. J Am Coll Cardiol. 2002 Aug 7;40(3):446-52 [PMID: 12142109]
  2. J Am Coll Cardiol. 2004 Sep 1;44(5):1053-8 [PMID: 15337218]
  3. J Cardiovasc Electrophysiol. 2006 Jan;17(1):11-5 [PMID: 16426392]
  4. Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):676-86 [PMID: 17001205]
  5. Circulation. 2006 Oct 10;114(15):1633-44 [PMID: 17030703]
  6. Br J Sports Med. 2009 Sep;43(9):669-76 [PMID: 19734501]
  7. N Engl J Med. 2010 Jul 1;363(1):36-44 [PMID: 20463331]
  8. Circ Arrhythm Electrophysiol. 2011 Apr;4(2):185-94 [PMID: 21270104]
  9. Am J Cardiol. 2011 Mar 1;107(5):697-703 [PMID: 21316505]
  10. Br J Sports Med. 2012 Nov;46 Suppl 1:i44-50 [PMID: 23097479]
  11. Curr Opin Cardiol. 2013 Jan;28(1):19-25 [PMID: 23128498]
  12. Am J Cardiol. 2013 Feb 15;111(4):557-62 [PMID: 23219000]
  13. Circulation. 2013 May 21;127(20):2021-30 [PMID: 23690453]
  14. J Am Coll Cardiol. 2013 Oct 1;62(14):1290-1297 [PMID: 23871885]
  15. Am Heart J. 1985 Sep;110(3):560-7 [PMID: 2412427]
  16. Am J Cardiol. 2013 Nov 1;112(9):1396-402 [PMID: 24135302]
  17. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):237-43 [PMID: 24523413]
  18. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):198-204 [PMID: 24585715]
  19. Eur Heart J. 2014 Nov 21;35(44):3097-102 [PMID: 24713647]
  20. Heart Rhythm. 2015 Jan;12(1):78-85 [PMID: 25239428]
  21. J Am Heart Assoc. 2014 Dec;3(6):e001471 [PMID: 25516436]
  22. Eur Heart J. 2015 Aug 7;36(30):1998-2010 [PMID: 26038590]
  23. J Am Coll Cardiol. 2015 Jul 14;66(2):101-9 [PMID: 26160626]
  24. Br J Sports Med. 2016 Jan;50(2):111-7 [PMID: 26224114]
  25. Heart Rhythm. 2015 Dec;12(12):2488-98 [PMID: 26272522]
  26. Eur Heart J. 2015 Nov 1;36(41):2793-2867 [PMID: 26320108]
  27. Heart Rhythm. 2016 Jan;13(1):199-207 [PMID: 26321091]
  28. J Am Coll Cardiol. 2015 Dec 1;66(21):2412-2423 [PMID: 26542670]
  29. Circulation. 2015 Dec 1;132(22):e262-6 [PMID: 26621643]
  30. Circulation. 2015 Dec 1;132(22):e292-7 [PMID: 26621646]
  31. Arrhythm Electrophysiol Rev. 2013 Nov;2(2):99-104 [PMID: 26835048]
  32. Am J Med. 2016 Nov;129(11):1170-1177 [PMID: 27039955]
  33. J Am Coll Cardiol. 2016 May 10;67(18):2108-2115 [PMID: 27151341]
  34. Card Electrophysiol Clin. 2016 Sep;8(3):631-9 [PMID: 27521096]
  35. Nat Rev Cardiol. 2017 Feb;14(2):88-101 [PMID: 27830772]
  36. J Am Coll Cardiol. 2016 Dec 13;68(23):2540-2550 [PMID: 27931611]
  37. Heart Asia. 2017 Jan 4;9(1):14-24 [PMID: 28123456]
  38. J Am Coll Cardiol. 2017 Feb 7;69(5):497-507 [PMID: 28153106]
  39. Card Electrophysiol Clin. 2017 Mar;9(1):11-24 [PMID: 28167079]
  40. Eur Heart J. 2018 Apr 21;39(16):1466-1480 [PMID: 28329355]
  41. Circulation. 2017 Jun 6;135(23):2310-2312 [PMID: 28584032]
  42. Heart Rhythm. 2018 Jan;15(1):99-106 [PMID: 28765087]
  43. Circ Res. 2017 Sep 15;121(7):784-802 [PMID: 28912183]
  44. Curr Treat Options Cardiovasc Med. 2017 Oct 9;19(11):86 [PMID: 28990149]
  45. Heart Rhythm. 2018 Feb;15(2):159-163 [PMID: 29405947]
  46. Expert Rev Cardiovasc Ther. 2018 Apr;16(4):277-286 [PMID: 29463140]
  47. Heart Rhythm. 2018 Oct;15(10):1477-1483 [PMID: 29678777]
  48. JACC Clin Electrophysiol. 2015 Jun;1(3):116-123 [PMID: 29759353]
  49. J Am Heart Assoc. 2018 Jun 9;7(12):null [PMID: 29886418]
  50. J Am Heart Assoc. 2018 Jun 16;7(12):null [PMID: 29909402]
  51. JACC Clin Electrophysiol. 2018 Jun;4(6):744-753 [PMID: 29929667]
  52. Eur J Prev Cardiol. 2018 Dec;25(18):2003-2011 [PMID: 30160531]
  53. Heart Rhythm. 2019 Feb;16(2):239-248 [PMID: 30172028]
  54. JACC Clin Electrophysiol. 2018 Sep;4(9):1141-1150 [PMID: 30236386]
  55. Heart. 2019 Jan;105(2):144-151 [PMID: 30242141]
  56. Heart Rhythm. 2019 Apr;16(4):536-543 [PMID: 30366162]
  57. Arrhythm Electrophysiol Rev. 2018 Aug;7(3):181-186 [PMID: 30416731]
  58. Cardiology. 1994;84(1):42-50 [PMID: 8149388]
  59. JAMA. 1996 Jul 17;276(3):199-204 [PMID: 8667563]

Word Cloud

Created with Highcharts 10.0.0ventricularathletescardiomyopathyarrhythmiascardiacsportsheartVentricularmanagerisksuddendeathSCDMonomorphicMMVAcomprehensivestructuraldiseasehypertrophicarrhythmogenicrightchallengingconcernelevatedcompetitionoftenbenignstructurallynormalalsoassociateduniquesubsetidiopathicmalignantsubstratesmustclearlydefinedevaluationand/orelectricalrequiredorderexcludeconditionsincreaseexerciseUniqueissuesphysicianspopulationincludenavigatingdecisionwhethercansafelycontinuechosensportabsencetherapiesradiofrequencycatheterablationeffectivecertainmayallowreturncompetitiveparticipationreviewsummariserecommendationsevaluatingmanagingArrhythmiasAthletesAblationathleteprematurecontractioncardiologytachycardia

Similar Articles

Cited By